Docusign (BUE:DOCU) Research & Development: ARS930,204.13 Mil (TTM As of Apr. 2026)


What is Docusign Research & Development?

Docusign BUE:DOCU 66 Research & Development is ARS930,204.13 Mil as of Apr. 2026. GuruFocus rates BUE:DOCU with a GF Score™ of 66/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Docusign's Research & Development for the three months ended in Apr. 2026 was ARS221,983.34 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was ARS930,204.13 Mil.

Docusign  (BUE:DOCU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Docusign Research & Development Related Terms

Docusign Research & Development Historical Data

* Premium members only.

The historical data trend for Docusign's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Docusign Research & Development Chart

Docusign Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40,390.41 84,990.73 436,149.07 618,607.41 960,285.73

Docusign Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 185,755.95 223,912.77 241,296.81 243,011.20 221,983.34

Docusign Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS930,204.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ARS930,204.13 Mil mean?
Docusign (BUE:DOCU) has a Research & Development of ARS930,204.13 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on Docusign and its competitors.
Is Docusign's Research & Development too high?
Docusign's current Research & Development is ARS930,204.13 Mil. Overall, Docusign has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Docusign's Research & Development compare to BSY and FROG?
Docusign's Research & Development of ARS930,204.13 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Docusign and its competitors. Docusign's current Research & Development is ARS930,204.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Docusign stock overvalued right now?
Docusign (BUE:DOCU) has a current Research & Development of ARS930,204.13 Mil. The current Research & Development is ARS930,204.13 Mil. Docusign's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Docusign (BUE:DOCU), the current Research & Development is ARS930,204.13 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Docusign Business Description

Address 221 Main Street, Suite 800, San Francisco, CA, USA, 94105
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.